Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model

被引：0
作者：
Septiara Putri
Ryan R. Nugraha
Eka Pujiyanti
Hasbullah Thabrany
Hanifah Hasnur
Novita D. Istanti
Diah Evasari
机构：
[1] University of Indonesia,Health Policy and Administration Department, Faculty of Public Health
[2] University of Indonesia,Center for Health Economics and Policy Studies (CHEPS)
[3] Universitas Padjajaran,Internal Medicine Department, Faculty of Medicine
来源：
BMC Research Notes | / 15卷
关键词：
Peritoneal dialysis; Hemodialysis; End stage renal disease; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 97 条
  • [1] Thurlow JS(2021)Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy Am J Nephrol 52 98-107
  • [2] Joshi M(2020)Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 395 709-733
  • [3] Yan G(2016)The economic burden of chronic kidney disease and end-stage renal disease Semin Nephrol 36 319-330
  • [4] Norris KC(2017)Update on the burden of CKD J Am Soc Nephrol 28 1020-1022
  • [5] Agodoa LY(2015)Worldwide access to treatment for end-stage kidney disease: a systematic review Lancet 385 1975-1982
  • [6] Yuan CM(2011)Global variation in renal replacement therapy for end-stage renal disease Nephrol Dial Transplant 26 2604-2610
  • [7] Bikbov B(2017)Cost effectiveness analysis between hemodialysis and peritoneal dialysis J Ekon Kesehat Indones 14 1142-1145
  • [8] Purcell CA(2017)Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia PLoS ONE 35 1153-1165
  • [9] Levey AS(2011)Estimating population-based values for EQ-5D health states in Thailand Value Heal 2016 925-930
  • [10] Smith M(2017)The Indonesian EQ-5D-5L Value Set Pharmacoeconomics 14 1-16
12345678910